Addition of testosterone to endocrine care for transgender women: a dose-finding and feasibility trial.
Noor C GielesMaurice A G M KroonStephanie BothAnnemieke C HeijboerBaudewijntje P C KreukelsMartin den HeijerPublished in: European journal of endocrinology (2024)
The use of testosterone supplementation in transgender women seems feasible and safe in the short term. Although dosing requires personalized titration, stable testosterone levels can be established. A blinded, placebo-controlled, randomized clinical trial is needed to study the clinical benefit.
Keyphrases
- replacement therapy
- placebo controlled
- polycystic ovary syndrome
- study protocol
- double blind
- phase iii
- phase ii
- pregnancy outcomes
- healthcare
- clinical trial
- hiv testing
- cervical cancer screening
- randomized controlled trial
- breast cancer risk
- quality improvement
- smoking cessation
- men who have sex with men
- pain management
- open label
- insulin resistance
- squamous cell carcinoma
- phase ii study
- metabolic syndrome
- affordable care act
- rectal cancer
- hiv infected